Icon
+91 94997 68112
Login Register

Genvoya - (150mg/150mg/200mg/10mg; Tablet)

Elvitegravir, Cobicistat, Emtricitabine, Tenofovir Alafenamide Gilead
150mg/150mg/200mg/10mg; Tablet
More Than $1000 mn
Less Than 5
Less Than 5
Less Than 5
 None
None None
GENVOYA is a four-drug combination of elvitegravir (EVG), an HIV-1 integrase strand transfer inhibitor (INSTI), cobicistat (COBI), a CYP3A inhibitor, and emtricitabine (FTC) and tenofovir alafenamide (TAF), both HIV-1 nucleoside analog reverse transcriptase inhibitors (NRTIs), and is indicated as a complete regimen for the treatment of HIV-1 infection in adults and pediatric patients weighing at least 25 kg who have no antiretroviral treatment history or to replace the current antiretroviral regimen in those who are virologically-suppressed (HIV-1 RNA less than 50 copies per mL) on a stable antiretroviral regimen for at least 6 months with no history of treatment failure and no known substitutions associated with resistance to the individual components of GENVOYA.
Yes
****** ***** **** **. ******, *********** *** *** (******) ***** ** *** ****. ********* ** ****** ****** ** ******, ******** ****** *** ******* ******* ** ****. (*** ******* ******** ** **** *** '*** *** '***.)
Genvoya Patent 1 Patent 2 Patent 3 Patent 4 Patent 5 Patent 6 Patent 7 Patent 8 Patent 9 Patent 10
****** *** ********* *** ********* *** ********* *** ********* *** ********* **** ** *** **, **** *** ********* **** ** *** **, **** *** ********* **** ** *** **, ****
Company FTF Status / 180 days exclusivity 30-Months stay Current Litigation Status Current Approval Status Likelihood of launch
****** *** / ********* *** **, **** ******* **** ***** *** **** (******** ******)
  1. *** **, **** : * ****-** ** ***** *** ***** ** *** *** *******.
  2. *** *, **** : ****** ******** ****** ** ***** **** ** ******.
  3. *** **, **** : ****** **** ****** **** ************ ** ******* '***, '***, *** '***.

Download ParaIV Report

Download ParaIV Detailed Report

To get detailed report Contact Us

ParaIV Advanced Search






Please contact contact@researchdelta.com to get more details.

Headquarters

Research Delta Advisor, G4,Sani Apartment, Bank of india lane, Ellora park, Vadodara 390023

+91 94997 68112

nimish@researchdelta.com

Products & Services

Para IV GenUS Pharmalysis Consulting Valuation

Quick Links

Home About Career Media Coverage Contact
© Research Delta, All Right Reserved.